genprowebdirectory
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2023
Grail
Industry News
Illumina Links Grail Divestiture to Losing European Or U.S. Appeals
Alex Philippidis
-
October 14, 2023
0
Industry News
European Commission Orders Illumina to Divest of Grail
Alex Philippidis
-
October 12, 2023
0
News
Illumina Vows Appeal of $479M Fine for Acquiring Grail before EC Approval
Alex Philippidis
-
July 12, 2023
0
Drug Discovery
StockWatch: FTC vs. Amgen-Horizon Could Slam Brakes on Biotech M&A
Alex Philippidis
-
May 17, 2023
18
Cancer
AACR News: GRAIL Validates Methylation-Based Cancer Detection Test
Julianna LeMieux, PhD
-
April 21, 2023
0
GEN Edge
StockWatch: Illumina Shares Steady as Icahn Escalates Proxy Fight
Alex Philippidis
-
April 7, 2023
0
Insights
Exclusive: RBC Analyst Weighs in on Icahn’s Proxy Battle for Illumina
Alex Philippidis
-
April 6, 2023
0
Scroll Up